Angiopoietin-like 4 (ANGPTL4, Fasting-induced Adipose Factor) Is a Direct Glucocorticoid Receptor Target and Participates in Glucocorticoid-regulated Triglyceride Metabolism

Suneil K. Koliwad, Taiyi Kuo, Lauren E. Shipp, Nora E. Gray, Fredrik Bäckhed, Alex Yick‐Lun So, Robert V. Farese, Jen-Chywan Wang

Journal of Biological Chemistry · 2009 · 163 citations · 31 references

DOIFull text

Open access

Concepts

Abstract

Glucocorticoids are important regulators of lipid homeostasis, and chronically elevated glucocorticoid levels induce hypertriglyceridemia, hepatic steatosis, and visceral obesity. The occupied glucocorticoid receptor (GR) is a transcription factor. However, those genes regulating lipid metabolism under GR control are not fully known. Angiopoietin-like 4 (ANGPTL4, fasting-induced adipose factor), a protein inhibitor of lipoprotein lipase, is synthesized and secreted during fasting, when circulating glucocorticoid levels are physiologically increased. We therefore tested whether the ANGPTL4 gene (Angptl4) is transcriptionally controlled by GR. We show that treatment with the synthetic glucocorticoid dexamethasone increased Angptl4 mRNA levels in primary hepatocytes and adipocytes (2–3-fold) and in the livers and white adipose tissue of mice (∼4-fold). We tested the mechanism of this increase in H4IIE hepatoma cells and found that dexamethasone treatment increased the transcriptional rate of Angptl4. Using bioinformatics and chromatin immunoprecipitation, we identified a GR binding site within the rat Angptl4 sequence. A reporter plasmid containing this site was markedly activated by dexamethasone, indicative of a functional glucocorticoid response element. Dexamethasone treatment also increased histone H4 acetylation and DNase I accessibility in genomic regions near this site, further supporting that it is a glucocorticoid response element. Glucocorticoids promote the flux of triglycerides from white adipose tissue to liver. We found that mice lacking ANGPTL4 (Angptl4−/−) had reductions in dexamethasone-induced hypertriglyceridemia and hepatic steatosis, suggesting that ANGPTL4 is required for this flux. Overall, we establish that ANGPTL4 is a direct GR target that participates in glucocorticoid-regulated triglyceride metabolism. Glucocorticoids are important regulators of lipid homeostasis, and chronically elevated glucocorticoid levels induce hypertriglyceridemia, hepatic steatosis, and visceral obesity. The occupied glucocorticoid receptor (GR) is a transcription factor. However, those genes regulating lipid metabolism under GR control are not fully known. Angiopoietin-like 4 (ANGPTL4, fasting-induced adipose factor), a protein inhibitor of lipoprotein lipase, is synthesized and secreted during fasting, when circulating glucocorticoid levels are physiologically increased. We therefore tested whether the ANGPTL4 gene (Angptl4) is transcriptionally controlled by GR. We show that treatment with the synthetic glucocorticoid dexamethasone increased Angptl4 mRNA levels in primary hepatocytes and adipocytes (2–3-fold) and in the livers and white adipose tissue of mice (∼4-fold). We tested the mechanism of this increase in H4IIE hepatoma cells and found that dexamethasone treatment increased the transcriptional rate of Angptl4. Using bioinformatics and chromatin immunoprecipitation, we identified a GR binding site within the rat Angptl4 sequence. A reporter plasmid containing this site was markedly activated by dexamethasone, indicative of a functional glucocorticoid response element. Dexamethasone treatment also increased histone H4 acetylation and DNase I accessibility in genomic regions near this site, further supporting that it is a glucocorticoid response element. Glucocorticoids promote the flux of triglycerides from white adipose tissue to liver. We found that mice lacking ANGPTL4 (Angptl4−/−) had reductions in dexamethasone-induced hypertriglyceridemia and hepatic steatosis, suggesting that ANGPTL4 is required for this flux. Overall, we establish that ANGPTL4 is a direct GR target that participates in glucocorticoid-regulated triglyceride metabolism. Glucocorticoids are steroid hormones that act as key transcriptional regulators of human metabolism during the fasted state, when their levels are physiologically increased. In particular, glucocorticoids facilitate the mobilization of triglycerides (TG) 2The abbreviations used are: TGtriglycerideWATwhite adipose tissueDEXdexamethasoneLPLlipoprotein lipaseDMSOdimethyl sulfoxideChIPchromatin immunoprecipitationPPARperoxisome proliferator-activated receptorERKextracellular signal-regulated kinaseqPCRquantitative PCRPBSphosphate-buffered salineEMSAelectrophoretic mobility shift assayDBDDNA binding domainMAP kinasemitogen-activated protein kinasePepckphosphoenolpyruvate carboxykinaseGRglucocorticoid receptorGREglucocorticoid receptor element. 2The abbreviations used are: TGtriglycerideWATwhite adipose tissueDEXdexamethasoneLPLlipoprotein lipaseDMSOdimethyl sulfoxideChIPchromatin immunoprecipitationPPARperoxisome proliferator-activated receptorERKextracellular signal-regulated kinaseqPCRquantitative PCRPBSphosphate-buffered salineEMSAelectrophoretic mobility shift assayDBDDNA binding domainMAP kinasemitogen-activated protein kinasePepckphosphoenolpyruvate carboxykinaseGRglucocorticoid receptorGREglucocorticoid receptor element. from the white adipose tissue (WAT) for use by the liver in processes such as gluconeogenesis, TG synthesis, and very low density lipoporotein synthesis and secretion (1Macfarlane D.P. Forbes S. Walker B.R. J. Endocrinol. 2008; 197: 189-204Crossref PubMed Scopus (259) Google Scholar, 2Seckl J.R. Morton N.M. Chapman K.E. Walker B.R. Recent Prog. Horm. Res. 2004; 59: 359-393Crossref PubMed Scopus (198) Google Scholar). However, the full set of genes that mediate this effect via transcriptional control by glucocorticoids is not known. triglyceride white adipose tissue dexamethasone lipoprotein lipase dimethyl sulfoxide chromatin immunoprecipitation peroxisome proliferator-activated receptor extracellular signal-regulated kinase quantitative PCR phosphate-buffered saline electrophoretic mobility shift assay DNA binding domain mitogen-activated protein kinase phosphoenolpyruvate carboxykinase glucocorticoid receptor glucocorticoid receptor element. triglyceride white adipose tissue dexamethasone lipoprotein lipase dimethyl sulfoxide chromatin immunoprecipitation peroxisome proliferator-activated receptor extracellular signal-regulated kinase quantitative PCR phosphate-buffered saline electrophoretic mobility shift assay DNA binding domain mitogen-activated protein kinase phosphoenolpyruvate carboxykinase glucocorticoid receptor glucocorticoid receptor element. Fasting also increases circulating levels of angiopoietin-like 4 (ANGPTL4, a fasting-induced adipose factor). ANGPTL4 is a protein secreted by the liver and WAT that can inhibit lipoprotein lipase (LPL) activity and stimulate WAT lipolysis (3Hato T. Tabata M. Oike Y. Trends Cardiovasc. Med. 2008; 18: 6-14Crossref PubMed Scopus (253) Google Scholar, 4Kersten S. Biochem. Soc. Trans. 2005; 33: 1059-1062Crossref PubMed Scopus (108) Google Scholar, 5Li C. Curr. Opin. Lipidol. 2006; 17: 152-156Crossref PubMed Scopus (62) Google Scholar). LPL hydrolyzes lipoprotein TG, promoting fatty acid storage in the WAT. This activity is counterbalanced by that of lipases, which hydrolyze stored TG, promoting fatty acid release by adipocytes. Therefore, one could predict that reducing ANGPTL4 activity would promote WAT TG storage, whereas increasing it would favor lipolysis. This prediction is consistent with the results of genetic and physiological studies. First, mice lacking ANGPTL4 (Angptl4−/−) have decreased plasma TG levels and an increased capacity for weight gain (6Bäckhed F. Ding H. Wang T. Hooper L.V. Koh G.Y. Nagy A. Semenkovich C.F. Gordon J.I. Proc. Natl. Acad. Sci. U.S.A. 2004; 101: 15718-15723Crossref PubMed Scopus (4103) Google Scholar). By contrast, mice overexpressing Angptl4 in the WAT have a dramatically limited capacity for TG storage and increased levels of plasma TG, fatty acids, and glycerol (7Mandard S. Zandbergen F. van Straten E. Wahli W. Kuipers F. Müller M. Kersten S. J. Biol. Chem. 2006; 281: 934-944Abstract Full Text Full Text PDF PubMed Scopus (340) Google Scholar). Plasma TG and fatty acid levels are similarly increased in mice by adenoviral overexpression of Angptl4 in the liver (8Xu A. Lam M.C. Chan K.W. Wang Y. Zhang J. Hoo R.L. Xu J.Y. Chen B. Chow W.S. Tso A.W. Lam K.S. Proc. Natl. Acad. Sci. U.S.A. 2005; 102: 6086-6091Crossref PubMed Scopus (245) Google Scholar) and by systemic injection of recombinant ANGPTL4 (9Akiyama T.E. Lambert G. Nicol C.J. Matsusue K. Peters J.M. Brewer Jr., H.B. Gonzalez F.J. J. Biol. Chem. 2004; 279: 20874-20881Abstract Full Text Full Text PDF PubMed Scopus (82) Google Scholar, 10Yoshida K. Shimizugawa T. Ono M. Furukawa H. J. Lipid Res. 2002; 43: 1770-1772Abstract Full Text Full Text PDF PubMed Scopus (300) Google Scholar). Finally, a recent large population-based study uncovered sequence variations in Angptl4 that are associated with loss of function and reduced plasma TG levels in humans (11Romeo S. Pennacchio L.A. Fu Y. Boerwinkle E. Tybjaerg-Hansen A. Hobbs H.H. Cohen J.C. Nat. Genet. 2007; 39: 513-516Crossref PubMed Scopus (418) Google Scholar). In summary, these data suggest that transcriptional modulation of Angptl4 expression could serve as an important regulatory mechanism in TG homeostasis. We previously showed that Angptl4 mRNA levels are increased by glucocorticoids in A549 lung epithelial cells, suggesting that glucocorticoids may exert transcriptional control over Angptl4 expression (12Wang J.C. Derynck M.K. Nonaka D.F. Khodabakhsh D.B. Haqq C. Yamamoto K.R. Proc. Natl. Acad. Sci. U.S.A. 2004; 101: 15603-15608Crossref PubMed Scopus (252) Google Scholar). Several lines of evidence support this hypothesis in metabolic tissues. First, excess glucocorticoids promote hypertriglyceridemia, as also seen in models where ANGPTL4 levels are increased (1Macfarlane D.P. Forbes S. Walker B.R. J. Endocrinol. 2008; 197: 189-204Crossref PubMed Scopus (259) Google Scholar, 13Walker B.R. Diabet. Med. 2006; 23: 1281-1288Crossref PubMed Scopus (146) Google Scholar, 14Walker B.R. Eur. J. Endocrinol. 2007; 157: 545-559Crossref PubMed Scopus (369) Google Scholar). Second, reducing the ratio of active to inactive glucocorticoids by pharmacologically inhibiting 11β-hydroxysteroid dehydrogenase type I increased plasma TG clearance and decreased liver TG synthesis, two components of the phenotype seen in Angptl4−/− mice (6Bäckhed F. Ding H. Wang T. Hooper L.V. Koh G.Y. Nagy A. Semenkovich C.F. Gordon J.I. Proc. Natl. Acad. Sci. U.S.A. 2004; 101: 15718-15723Crossref PubMed Scopus (4103) Google Scholar, 15Desai U. Lee E.C. Chung K. Gao C. Gay J. Key B. Hansen G. Machajewski D. Platt K.A. Sands A.T. M. A. J. G. Proc. Natl. Acad. Sci. U.S.A. 2007; PubMed Scopus (146) Google Scholar). Therefore, it is that and to glucocorticoids may the of Angptl4 expression in metabolic tissues. However, whether Angptl4 expression is by glucocorticoids in the liver and WAT the of ANGPTL4 in systemic TG we the of Angptl4 by We whether glucocorticoids Angptl4 expression in primary hepatocytes and livers and and We the mechanism of glucocorticoid-regulated Angptl4 expression a rat hepatoma Finally, we used Angptl4−/− mice to the of ANGPTL4 in glucocorticoid-regulated TG homeostasis. H4IIE rat hepatoma cells from in with cells with dexamethasone with was primary hepatocytes from primary adipocytes from H4IIE cells to by a of for The chromatin immunoprecipitation as previously E.C. C. Haqq H. Yamamoto K.R. 2007; PubMed Scopus Google Scholar, J.C. C. Yamamoto K.R. 2006; PubMed Scopus Google Scholar). H4IIE cells to and with for and in and 4 for by 4 for The from of the and of used for in We the two was in of in transcription 4 4 of and and of and the in of in transcription of for of and of DNase to the was in A for in for and in and of of of to for and for the and the The with of and with of The in of and of used for transcription to quantitative PCR was from cells by and from liver and WAT was by of 4 of and of and for A containing of of and of was and for The was for The was to and was used to in a containing DNA I and of was used the was in an DNA a PCR and by the as by the expression was used for are in and WAT in and stored and in and with by for 4 by and to for with in 4 in with containing primary by with for in with containing by with by for in with of with for and for 4 in with with primary The ANGPTL4 to and as to and The density of the ANGPTL4 by that of the are The rat Angptl4 genomic containing the GR binding site was by PCR The PCR was and the A was used to the from H4IIE cells with for with of DNase I for The was by treatment with for DNA PCR The to the of for which used to the of DNA by DNase in H4IIE cells was with to the cells with and activity was by a assay to the of GR DNA binding domain protein by of with containing Angptl4 with in a of 4 and The for to and and by a mice from The Angptl4−/− mice by the of Nagy and Gordon mice a as (6Bäckhed F. Ding H. Wang T. Hooper L.V. Koh G.Y. Nagy A. Semenkovich C.F. Gordon J.I. Proc. Natl. Acad. Sci. U.S.A. 2004; 101: 15718-15723Crossref PubMed Scopus (4103) Google and and Angptl4−/− by mice The PCR for previously (6Bäckhed F. Ding H. Wang T. Hooper L.V. Koh G.Y. Nagy A. Semenkovich C.F. Gordon J.I. Proc. Natl. Acad. Sci. U.S.A. 2004; 101: 15718-15723Crossref PubMed Scopus (4103) Google Scholar). with weight of in for 4 the mice fasted for 4 J.C. C. Yamamoto K.R. 2006; PubMed Scopus Google Scholar) and used for and tissue in and in a of and in and by with the acid The TG by to and and as F. PubMed Scopus Google with as a and tissue was from and a was used to TG are as for and by whether Angptl4 expression is by glucocorticoids in primary rat hepatocytes and human we these cells with the synthetic glucocorticoid for the cells to was synthesized and was We that treatment increased the expression of and in hepatocytes and and not mRNA levels of and two genes not to by glucocorticoids treatment increased Angptl4 mRNA levels in hepatocytes and that Angptl4 expression is by glucocorticoids in We tested whether glucocorticoids Angptl4 expression in the rat hepatoma by these cells with for for primary treatment increased Angptl4 mRNA levels We to in H4IIE cells the effect of and Angptl4 mRNA expression in these cells was seen in primary whether glucocorticoids increase Angptl4 expression in we the livers and WAT from mice for 4 with We used these to and to mRNA treatment increased the levels of mRNA had effect mRNA levels in liver and WAT However, as it in primary hepatocytes and treatment of mice increased Angptl4 mRNA levels in the liver and WAT that Angptl4 is by glucocorticoids in We to whether the increase in Angptl4 mRNA expression by treatment is associated with an increase in ANGPTL4 protein We tissue from control and and found that treatment for 4 markedly elevated the levels of ANGPTL4 protein in the WAT and liver and S. Zandbergen F. D. W. A. F. Wahli W. Müller M. Kersten S. J. Biol. Chem. 2004; 279: Full Text Full Text PDF PubMed Scopus Google Scholar, J.C. B. Y. A. J.M. Biol. PubMed Scopus Google Scholar) showed that the WAT an of ANGPTL4 whereas the liver of a of results from the WAT and livers of mice with these We whether the of Angptl4 mRNA by glucocorticoid treatment is to an increase in the rate of Angptl4 transcription in H4IIE cells by with in for cells with for from these cells, and in transcription was by synthesized was was was to in transcription Angptl4 effect was seen of treatment However, of and markedly increased the rate of Angptl4 transcription results that glucocorticoids can Angptl4 the transcriptional whether transcription of Angptl4 is by the we to GR binding within the Angptl4 genomic sequence. We a with which we identified within of rat Angptl4 and of the transcriptional that of the was set to previously identified GR binding M. Yamamoto K.R. Proc. Natl. Acad. Sci. U.S.A. 2008; PubMed Scopus Google Scholar). important transcriptional regulatory regions within genes are we a of the of to and the and human This a sequence the of Angptl4 and of the transcriptional site We used a assay to GR to this GR binding site in H4IIE for with and for Using a control for the of genomic DNA that in the GR binding site was control and not By contrast, a for we found that treatment in a of genomic DNA that the GR binding site This that GR of this sequence in a suggesting that this sequence may a functional whether this identified genomic GR binding site is to mediate to we the rat Angptl4 genomic DNA containing this sequence a reporter plasmid that expression of the gene This plasmid was H4IIE cells, and cells with with activity in H4IIE cells that this glucocorticoid the of this sequence in the glucocorticoid we a within it the is This was for as that it GR and is an important of glucocorticoid Xu Yamamoto K.R. PubMed Scopus Google Scholar, C. E.C. H. Yamamoto K.R. Genet. 2007; PubMed Scopus Google Scholar). of this reduced the glucocorticoid response by consistent with this sequence a functional Finally, we to the direct binding of GR to the Angptl4 We found that GR was to to Angptl4 and that this binding increased with the of GR protein in the by it of the GR to the Angptl4 as a a for Angptl4 which a in one of the two had a with GR GR could to the GR could consistent with decreased of Angptl4 by GR GR to as a these that GR and to the identified Angptl4 can control gene expression in by the accessibility of genomic to transcriptional B. M. 2007; Full Text Full Text PDF PubMed Scopus Google Scholar). in the of chromatin are by the the of DNA to by DNase I G. S. Biol. PubMed Scopus Google Scholar, S. 2008; Full Text Full Text PDF PubMed Scopus Google Scholar). accessibility to DNase I a chromatin whereas from by DNase I to a chromatin The is associated with transcriptional and the with We tested whether glucocorticoid treatment DNase I accessibility of genomic regions near the identified Angptl4 H4IIE cells with for the which increased the rate of Angptl4 transcriptional in and with DNase DNA was and was to for of genomic by DNase treatment markedly increased the accessibility of the Angptl4 and genomic regions to DNase I results suggest that glucocorticoid treatment the of chromatin in the of the Angptl4 consistent with the increase in transcription the of chromatin and a of DNA in an of of the and histone and with transcriptional M. Biochem. 2007; PubMed Scopus Google Scholar). We therefore whether glucocorticoids the acetylation of rat Angptl4. H4IIE cells with for which was to levels of histone and histone H4 in genomic regions of Angptl4. with for increased levels of in 4 genomic regions which the A and in to those of the levels of not by dexamethasone Overall, these results suggest that glucocorticoids induce acetylation of histone H4 in Angptl4 Plasma TG levels in mice are elevated by overexpression of Angptl4 (7Mandard S. Zandbergen F. van Straten E. Wahli W. Kuipers F. Müller M. Kersten S. J. Biol. Chem. 2006; 281: 934-944Abstract Full Text Full Text PDF PubMed Scopus (340) Google Scholar) and by injection of mice with recombinant ANGPTL4 protein (9Akiyama T.E. Lambert G. Nicol C.J. Matsusue K. Peters J.M. Brewer Jr., H.B. Gonzalez F.J. J. Biol. Chem. 2004; 279: 20874-20881Abstract Full Text Full Text PDF PubMed Scopus (82) Google Scholar, 10Yoshida K. Shimizugawa T. Ono M. Furukawa H. J. Lipid Res. 2002; 43: 1770-1772Abstract Full Text Full Text PDF PubMed Scopus (300) Google Scholar). In the adenoviral overexpression of Angptl4 results in and hepatic (8Xu A. Lam M.C. Chan K.W. Wang Y. Zhang J. Hoo R.L. Xu J.Y. Chen B. Chow W.S. Tso A.W. Lam K.S. Proc. Natl. Acad. Sci. U.S.A. 2005; 102: 6086-6091Crossref PubMed Scopus (245) Google Scholar). are also seen in of glucocorticoid such as We therefore whether ANGPTL4 participates in the of glucocorticoids lipid metabolism in mice lacking ANGPTL4 (Angptl4−/−) (6Bäckhed F. Ding H. Wang T. Hooper L.V. Koh G.Y. Nagy A. Semenkovich C.F. Gordon J.I. Proc. Natl. Acad. Sci. U.S.A. 2004; 101: 15718-15723Crossref PubMed Scopus (4103) Google Scholar). Angptl4−/− mice and with for 4 their and livers to TG treatment of mice increased TG levels by the TG levels in Angptl4−/− mice and to treatment a for ANGPTL4 in this of lipid metabolism. treatment also increased liver TG levels in mice In Angptl4−/− of hepatic TG was Angptl4−/− livers from the of Overall, these establish ANGPTL4 as an important in glucocorticoid-regulated lipid in important of the response to is an increase in the of circulating which levels of in by promoting the flux of TG from the WAT to the liver. Fasting also increases synthesis and secretion of ANGPTL4 by the WAT and the hypothesis that ANGPTL4 may mediate of the regulatory effect of glucocorticoids metabolism. We therefore whether Angptl4 is transcriptionally by We establish that Angptl4 mRNA levels are by treatment in adipocytes and and in the WAT and livers of Using bioinformatics and we identified a GR binding site in the genomic of Angptl4. By that treatment reporter activity in cells this binding site to we that this site is a functional we used to show that this with GR. data suggest that the mechanism by which GR Angptl4 transcription the modulation of DNase I accessibility and histone acetylation within the We these to in by mice lacking mice had reductions in hypertriglyceridemia and hepatic steatosis, that ANGPTL4 is required for these Overall, we show that Angptl4 is a direct transcriptional target of GR and a to the of TG by glucocorticoids in have also to Angptl4 Angptl4 transcription is increased by in cells B. 2007; PubMed Scopus Google Scholar, S. C. A. C. J. J. M. J.M. S. J. Full Text Full Text PDF PubMed Scopus Google Scholar). By contrast, levels of Angptl4 mRNA in mice (6Bäckhed F. Ding H. Wang T. Hooper L.V. Koh G.Y. Nagy A. Semenkovich C.F. Gordon J.I. Proc. Natl. Acad. Sci. U.S.A. 2004; 101: 15718-15723Crossref PubMed Scopus (4103) Google Scholar). In to by as Angptl4 transcription is also controlled by peroxisome proliferator-activated and and which function as in hepatocytes and S. Zandbergen F. D. W. A. F. Wahli W. Müller M. Kersten S. J. Biol. Chem. 2004; 279: Full Text Full Text PDF PubMed Scopus Google Scholar, J.C. B. Y. A. J.M. Biol. PubMed Scopus Google Scholar). In particular, increases the expression of key genes in the metabolic response to B. Wahli W. 2006; PubMed Scopus Google Scholar). However, the effect of Angptl4 mRNA levels is not in mice lacking S. Zandbergen F. D. W. A. F. Wahli W. Müller M. Kersten S. J. Biol. Chem. 2004; 279: Full Text Full Text PDF PubMed Scopus Google suggesting that under GR as may mediate this mRNA levels are also increased by glucocorticoids T. B. B. J. Wahli W. J. Biol. Chem. Full Text PDF PubMed Google Scholar). it is that Angptl4 and are of a gene that the metabolic to Using rat H4IIE hepatoma cells, we the the of Angptl4 mRNA expression by We found that glucocorticoids increased the transcriptional rate of Angptl4 and identified a GR binding site and of the transcriptional site within the We the of GR to this site by and showed that this site can GR in cells with a reporter plasmid containing this GR binding site, we to stimulate reporter activity with that this site as a this is and as a regulatory element. the sequence it is not for a to from the transcriptional to and to the transcriptional site over C. E.C. H. Yamamoto K.R. Genet. 2007; PubMed Scopus Google Scholar). in and genes have found to similarly E.C. C. Haqq H. Yamamoto K.R. 2007; PubMed Scopus Google Scholar, W. J. W. M. 2005; Full Text Full Text PDF PubMed Scopus Google Scholar, G. Endocrinol. 2008; PubMed Scopus Google Scholar). a study found a GR binding in human Angptl4 to as as of the transcriptional site a C. E.C. H. Yamamoto K.R. Genet. 2007; PubMed Scopus Google Scholar). The glucocorticoid in this human GR binding have not and we to in the rat this these human data with suggest the that transcriptional may to Angptl4 expression in and the activity of C. E.C. H. Yamamoto K.R. Genet. 2007; PubMed Scopus Google Scholar, G. S. Biol. PubMed Scopus Google Scholar). glucocorticoids Angptl4 we therefore tested whether treatment the chromatin and histone acetylation of Angptl4. We found that treatment increased the DNase I accessibility of genomic regions near the Angptl4 that by GR may the of chromatin in these regions and facilitate the binding of transcriptional Glucocorticoids also the acetylation of histone H4 in genomic regions near the Angptl4 suggesting that acetylation of key regulatory within these regions may serve as of Angptl4 histone not was by treatment the occupied GR a of histone in Angptl4 it is that histone acetylation is genomic regions not tested Overall, the increased DNase I accessibility and histone H4 acetylation in the identified the important for regulating Angptl4 seen previously Biochem. J. 2004; PubMed Scopus Google glucocorticoid treatment increased TG levels in the and livers of mice However, this response was in Angptl4−/− mice A and by inhibiting a in the mechanism by which glucocorticoids increase and hepatic TG treatment that of Biochem. J. 2004; PubMed Scopus Google found that glucocorticoid treatment increased the rate of hepatic TG synthesis, not very low density lipoporotein This could the mice we TG levels in the liver in the we not a in the of mice for 4 with not it is that glucocorticoid treatment a of WAT (1Macfarlane D.P. Forbes S. Walker B.R. J. Endocrinol. 2008; 197: 189-204Crossref PubMed Scopus (259) Google Scholar, H. J. H. Morton N.M. J.R. PubMed Scopus Google Scholar). whether ANGPTL4 a in this The ANGPTL4 hepatic are A is that a lipoprotein lipase inhibitor and a of WAT glucocorticoids TG from WAT for use in hepatic TG this may an activity of ANGPTL4 from to inhibit A recent showed that the domain of can the of kinase in cells Wang Y. Lam K.S. Zhang J. W. D. Xu A. Biol. 2008; PubMed Scopus Google Scholar). of mRNA expression showed that genes in fatty acid in the in Angptl4−/− mice F. Semenkovich C.F. Gordon J.I. Proc. Natl. Acad. Sci. U.S.A. 2007; PubMed Scopus Google Scholar). is the kinase fatty acid are similarly in the livers and WAT of Angptl4−/− and this is an important for is that Angptl4 is not the GR target that participates in the of liver TG metabolism. GR was to inhibit transcription of the of gene which a transcriptional in hepatic U. A. M. A. A. S. U. K. Kersten S. S. 2008; Full Text Full Text PDF PubMed Scopus Google Scholar). of the expression of lipase and protein of which TG of these two genes in the liver can in the of TG U. A. M. A. A. S. U. K. Kersten S. S. 2008; Full Text Full Text PDF PubMed Scopus Google Scholar). with suggest that glucocorticoids the transcription of of genes that can exert hepatic lipid metabolism. these GR target genes are as lipid metabolism in the liver and WAT are a of glucocorticoids lipid the of direct GR in the WAT and liver. of Angptl4 as a direct GR target is an important the of this metabolic regulatory ANGPTL4 as a key of the of glucocorticoids TG during Fasting TG levels are in humans and are elevated in with and type genetic sequence variations with the of ANGPTL4 with capacity to inhibit LPL associated with low plasma TG levels in to of in a large when with in of the S. W. J. Pennacchio L.A. Boerwinkle E. Hobbs H.H. Cohen J.C. J. Google Scholar). with the suggest that ANGPTL4 may mediate the metabolic of glucocorticoids TG metabolism similarly in in humans and We Yamamoto for support this Nagy for Angptl4−/− Gordon and for the of Angptl4−/− for for GR and for the assay with Angiopoietin-like 4 (ANGPTL4, fasting-induced adipose is a direct glucocorticoid receptor target and participates in glucocorticoid-regulated triglyceride of PDF

References

31